HEADER SIGNALING PROTEIN 05-MAR-17 5X93 TITLE HUMAN ENDOTHELIN RECEPTOR TYPE-B IN COMPLEX WITH ANTAGONIST K-8794 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOTHELIN B RECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ET-BR,ENDOTHELIN RECEPTOR NON-SELECTIVE TYPE,LYSIS PROTEIN, COMPND 5 LYSOZYME,MURAMIDASE; COMPND 6 EC: 3.2.1.17; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 OTHER_DETAILS: CHIMERA PROTEIN OF RESIDUES 66-303 FROM P24530, COMPND 10 LINKER, RESIDUES 61-161 FROM P00720, RESIDUES 311-407 FROM P24530. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ENTEROBACTERIA PHAGE T4; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 10665; SOURCE 5 GENE: EDNRB, ETRB; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: MODIFIED PFASTBAC KEYWDS ALPHA HELICAL, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR W.SHIHOYA,T.NISHIZAWA,K.YAMASHITA,K.HIRATA,A.OKUTA,K.TANI, AUTHOR 2 Y.FUJIYOSHI,T.DOI,O.NUREKI REVDAT 4 16-OCT-24 5X93 1 REMARK REVDAT 3 15-NOV-17 5X93 1 TITLE REVDAT 2 20-SEP-17 5X93 1 JRNL REVDAT 1 16-AUG-17 5X93 0 JRNL AUTH W.SHIHOYA,T.NISHIZAWA,K.YAMASHITA,A.INOUE,K.HIRATA, JRNL AUTH 2 F.M.N.KADJI,A.OKUTA,K.TANI,J.AOKI,Y.FUJIYOSHI,T.DOI,O.NUREKI JRNL TITL X-RAY STRUCTURES OF ENDOTHELIN ETB RECEPTOR BOUND TO JRNL TITL 2 CLINICAL ANTAGONIST BOSENTAN AND ITS ANALOG JRNL REF NAT. STRUCT. MOL. BIOL. V. 24 758 2017 JRNL REFN ESSN 1545-9985 JRNL PMID 28805809 JRNL DOI 10.1038/NSMB.3450 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.94 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 30498 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1524 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.9487 - 4.8905 0.99 2767 146 0.1986 0.2201 REMARK 3 2 4.8905 - 3.8826 1.00 2668 140 0.1742 0.2084 REMARK 3 3 3.8826 - 3.3921 1.00 2656 140 0.1899 0.1991 REMARK 3 4 3.3921 - 3.0821 1.00 2636 138 0.2029 0.2285 REMARK 3 5 3.0821 - 2.8612 1.00 2614 138 0.2163 0.2335 REMARK 3 6 2.8612 - 2.6925 1.00 2640 139 0.2066 0.2407 REMARK 3 7 2.6925 - 2.5577 1.00 2599 136 0.2326 0.2767 REMARK 3 8 2.5577 - 2.4464 1.00 2613 137 0.2574 0.3030 REMARK 3 9 2.4464 - 2.3522 1.00 2580 135 0.2733 0.3171 REMARK 3 10 2.3522 - 2.2711 1.00 2606 138 0.3097 0.3526 REMARK 3 11 2.2711 - 2.2001 1.00 2595 137 0.3566 0.3821 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.270 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.280 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.29 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.18 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 3807 REMARK 3 ANGLE : 0.759 5109 REMARK 3 CHIRALITY : 0.040 570 REMARK 3 PLANARITY : 0.010 606 REMARK 3 DIHEDRAL : 14.183 2371 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5X93 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-MAR-17. REMARK 100 THE DEPOSITION ID IS D_1300003121. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-DEC-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL32XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX225-HS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40026 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 41.941 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 6.980 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.5300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 500 DME, (NH4)2SO4, MOPS, PH 6.0, REMARK 280 LIPIDIC CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.19000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.19000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 37.06500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 73.74000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 37.06500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 73.74000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 54.19000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 37.06500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 73.74000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 54.19000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 37.06500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 73.74000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 420 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 S SO4 A1218 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1354 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1404 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 63 REMARK 465 GLY A 64 REMARK 465 GLY A 65 REMARK 465 LEU A 66 REMARK 465 ALA A 67 REMARK 465 PRO A 68 REMARK 465 ALA A 69 REMARK 465 GLU A 70 REMARK 465 VAL A 71 REMARK 465 PRO A 72 REMARK 465 LYS A 73 REMARK 465 GLY A 74 REMARK 465 ASP A 75 REMARK 465 ARG A 76 REMARK 465 THR A 77 REMARK 465 ALA A 78 REMARK 465 GLY A 79 REMARK 465 SER A 80 REMARK 465 PRO A 81 REMARK 465 PRO A 82 REMARK 465 ARG A 83 REMARK 465 THR A 84 REMARK 465 ALA A 405 REMARK 465 GLN A 406 REMARK 465 SER A 407 REMARK 465 PRO A 408 REMARK 465 SER A 409 REMARK 465 SER A 410 REMARK 465 GLU A 411 REMARK 465 ASN A 412 REMARK 465 LEU A 413 REMARK 465 TYR A 414 REMARK 465 PHE A 415 REMARK 465 GLN A 416 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 248 CG CD CE NZ REMARK 470 LYS A1040 CG CD CE NZ REMARK 470 ARG A1076 CD NE CZ NH1 NH2 REMARK 470 ARG A1082 CD NE CZ NH1 NH2 REMARK 470 ARG A1094 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 351 CG OD1 ND2 REMARK 470 ASP A 354 CG OD1 OD2 REMARK 470 ARG A 392 CD NE CZ NH1 NH2 REMARK 470 ASN A 395 CG OD1 ND2 REMARK 470 TRP A 404 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 404 CZ3 CH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 90 -157.54 -158.69 REMARK 500 PHE A 282 -57.85 -134.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLC A 1206 REMARK 610 OLC A 1210 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue K87 A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 1204 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 1205 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 1206 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 1207 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 1208 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 1209 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 1210 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 1211 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC A 1212 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CLR A 1213 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1214 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1215 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1216 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1217 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1218 DBREF 5X93 A 66 303 UNP P24530 EDNRB_HUMAN 66 303 DBREF 5X93 A 1018 1118 UNP P00720 ENLYS_BPT4 61 161 DBREF 5X93 A 311 407 UNP P24530 EDNRB_HUMAN 311 407 SEQADV 5X93 GLY A 63 UNP P24530 EXPRESSION TAG SEQADV 5X93 GLY A 64 UNP P24530 EXPRESSION TAG SEQADV 5X93 GLY A 65 UNP P24530 EXPRESSION TAG SEQADV 5X93 TYR A 124 UNP P24530 ARG 124 ENGINEERED MUTATION SEQADV 5X93 ALA A 154 UNP P24530 ASP 154 ENGINEERED MUTATION SEQADV 5X93 ALA A 270 UNP P24530 LYS 270 ENGINEERED MUTATION SEQADV 5X93 ASN A 1002 UNP P24530 LINKER SEQADV 5X93 ILE A 1003 UNP P24530 LINKER SEQADV 5X93 PHE A 1004 UNP P24530 LINKER SEQADV 5X93 GLU A 1005 UNP P24530 LINKER SEQADV 5X93 MET A 1006 UNP P24530 LINKER SEQADV 5X93 LEU A 1007 UNP P24530 LINKER SEQADV 5X93 ARG A 1008 UNP P24530 LINKER SEQADV 5X93 ILE A 1009 UNP P24530 LINKER SEQADV 5X93 ASP A 1010 UNP P24530 LINKER SEQADV 5X93 GLU A 1011 UNP P24530 LINKER SEQADV 5X93 GLY A 1012 UNP P24530 LINKER SEQADV 5X93 GLY A 1013 UNP P24530 LINKER SEQADV 5X93 GLY A 1014 UNP P24530 LINKER SEQADV 5X93 SER A 1015 UNP P24530 LINKER SEQADV 5X93 GLY A 1016 UNP P24530 LINKER SEQADV 5X93 GLY A 1017 UNP P24530 LINKER SEQADV 5X93 ALA A 1054 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 5X93 ARG A 1094 UNP P00720 ILE 137 ENGINEERED MUTATION SEQADV 5X93 ALA A 342 UNP P24530 SER 342 ENGINEERED MUTATION SEQADV 5X93 ALA A 381 UNP P24530 ILE 381 ENGINEERED MUTATION SEQADV 5X93 ALA A 396 UNP P24530 CYS 396 ENGINEERED MUTATION SEQADV 5X93 ALA A 400 UNP P24530 CYS 400 ENGINEERED MUTATION SEQADV 5X93 ALA A 405 UNP P24530 CYS 405 ENGINEERED MUTATION SEQADV 5X93 PRO A 408 UNP P24530 EXPRESSION TAG SEQADV 5X93 SER A 409 UNP P24530 EXPRESSION TAG SEQADV 5X93 SER A 410 UNP P24530 EXPRESSION TAG SEQADV 5X93 GLU A 411 UNP P24530 EXPRESSION TAG SEQADV 5X93 ASN A 412 UNP P24530 EXPRESSION TAG SEQADV 5X93 LEU A 413 UNP P24530 EXPRESSION TAG SEQADV 5X93 TYR A 414 UNP P24530 EXPRESSION TAG SEQADV 5X93 PHE A 415 UNP P24530 EXPRESSION TAG SEQADV 5X93 GLN A 416 UNP P24530 EXPRESSION TAG SEQRES 1 A 464 GLY GLY GLY LEU ALA PRO ALA GLU VAL PRO LYS GLY ASP SEQRES 2 A 464 ARG THR ALA GLY SER PRO PRO ARG THR ILE SER PRO PRO SEQRES 3 A 464 PRO CYS GLN GLY PRO ILE GLU ILE LYS GLU THR PHE LYS SEQRES 4 A 464 TYR ILE ASN THR VAL VAL SER CYS LEU VAL PHE VAL LEU SEQRES 5 A 464 GLY ILE ILE GLY ASN SER THR LEU LEU TYR ILE ILE TYR SEQRES 6 A 464 LYS ASN LYS CYS MET ARG ASN GLY PRO ASN ILE LEU ILE SEQRES 7 A 464 ALA SER LEU ALA LEU GLY ASP LEU LEU HIS ILE VAL ILE SEQRES 8 A 464 ALA ILE PRO ILE ASN VAL TYR LYS LEU LEU ALA GLU ASP SEQRES 9 A 464 TRP PRO PHE GLY ALA GLU MET CYS LYS LEU VAL PRO PHE SEQRES 10 A 464 ILE GLN LYS ALA SER VAL GLY ILE THR VAL LEU SER LEU SEQRES 11 A 464 CYS ALA LEU SER ILE ASP ARG TYR ARG ALA VAL ALA SER SEQRES 12 A 464 TRP SER ARG ILE LYS GLY ILE GLY VAL PRO LYS TRP THR SEQRES 13 A 464 ALA VAL GLU ILE VAL LEU ILE TRP VAL VAL SER VAL VAL SEQRES 14 A 464 LEU ALA VAL PRO GLU ALA ILE GLY PHE ASP ILE ILE THR SEQRES 15 A 464 MET ASP TYR LYS GLY SER TYR LEU ARG ILE CYS LEU LEU SEQRES 16 A 464 HIS PRO VAL GLN LYS THR ALA PHE MET GLN PHE TYR ALA SEQRES 17 A 464 THR ALA LYS ASP TRP TRP LEU PHE SER PHE TYR PHE CYS SEQRES 18 A 464 LEU PRO LEU ALA ILE THR ALA PHE PHE TYR THR LEU MET SEQRES 19 A 464 THR CYS GLU MET LEU ARG LYS ASN ILE PHE GLU MET LEU SEQRES 20 A 464 ARG ILE ASP GLU GLY GLY GLY SER GLY GLY ASP GLU ALA SEQRES 21 A 464 GLU LYS LEU PHE ASN GLN ASP VAL ASP ALA ALA VAL ARG SEQRES 22 A 464 GLY ILE LEU ARG ASN ALA LYS LEU LYS PRO VAL TYR ASP SEQRES 23 A 464 SER LEU ASP ALA VAL ARG ARG ALA ALA LEU ILE ASN MET SEQRES 24 A 464 VAL PHE GLN MET GLY GLU THR GLY VAL ALA GLY PHE THR SEQRES 25 A 464 ASN SER LEU ARG MET LEU GLN GLN LYS ARG TRP ASP GLU SEQRES 26 A 464 ALA ALA VAL ASN LEU ALA LYS SER ARG TRP TYR ASN GLN SEQRES 27 A 464 THR PRO ASN ARG ALA LYS ARG VAL ILE THR THR PHE ARG SEQRES 28 A 464 THR GLY THR TRP ASP ALA TYR LEU ASN ASP HIS LEU LYS SEQRES 29 A 464 GLN ARG ARG GLU VAL ALA LYS THR VAL PHE CYS LEU VAL SEQRES 30 A 464 LEU VAL PHE ALA LEU CYS TRP LEU PRO LEU HIS LEU ALA SEQRES 31 A 464 ARG ILE LEU LYS LEU THR LEU TYR ASN GLN ASN ASP PRO SEQRES 32 A 464 ASN ARG CYS GLU LEU LEU SER PHE LEU LEU VAL LEU ASP SEQRES 33 A 464 TYR ILE GLY ILE ASN MET ALA SER LEU ASN SER CYS ALA SEQRES 34 A 464 ASN PRO ILE ALA LEU TYR LEU VAL SER LYS ARG PHE LYS SEQRES 35 A 464 ASN ALA PHE LYS SER ALA LEU CYS CYS TRP ALA GLN SER SEQRES 36 A 464 PRO SER SER GLU ASN LEU TYR PHE GLN HET K87 A1201 49 HET OLC A1202 25 HET OLC A1203 25 HET OLC A1204 25 HET OLC A1205 25 HET OLC A1206 17 HET OLC A1207 25 HET OLC A1208 25 HET OLC A1209 25 HET OLC A1210 20 HET OLC A1211 25 HET OLC A1212 25 HET CLR A1213 28 HET SO4 A1214 5 HET SO4 A1215 5 HET SO4 A1216 5 HET SO4 A1217 5 HET SO4 A1218 5 HETNAM K87 3-[6-[(4-TERT-BUTYLPHENYL)SULFONYLAMINO]-5-(2- HETNAM 2 K87 METHOXYPHENOXY)-2-PYRIMIDIN-2-YL-PYRIMIDIN-4-YL]OXY-N- HETNAM 3 K87 (2,6-DIMETHYLPHENYL)PROPANAMIDE HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETNAM CLR CHOLESTEROL HETNAM SO4 SULFATE ION HETSYN OLC 1-OLEOYL-R-GLYCEROL FORMUL 2 K87 C36 H38 N6 O6 S FORMUL 3 OLC 11(C21 H40 O4) FORMUL 14 CLR C27 H46 O FORMUL 15 SO4 5(O4 S 2-) FORMUL 20 HOH *106(H2 O) HELIX 1 AA1 GLY A 92 ASN A 129 1 38 HELIX 2 AA2 ASN A 129 ASN A 134 1 6 HELIX 3 AA3 ASN A 137 GLU A 165 1 29 HELIX 4 AA4 GLY A 170 ALA A 204 1 35 HELIX 5 AA5 PRO A 215 GLY A 239 1 25 HELIX 6 AA6 THR A 263 PHE A 282 1 20 HELIX 7 AA7 PHE A 282 GLU A 1011 1 32 HELIX 8 AA8 GLY A 1017 ARG A 1037 1 21 HELIX 9 AA9 LYS A 1040 LEU A 1048 1 9 HELIX 10 AB1 ASP A 1049 GLY A 1064 1 16 HELIX 11 AB2 GLY A 1064 GLY A 1070 1 7 HELIX 12 AB3 PHE A 1071 GLN A 1080 1 10 HELIX 13 AB4 ARG A 1082 LYS A 1092 1 11 HELIX 14 AB5 SER A 1093 THR A 1099 1 7 HELIX 15 AB6 THR A 1099 GLY A 1113 1 15 HELIX 16 AB7 TRP A 1115 LEU A 311 5 5 HELIX 17 AB8 ASN A 312 TYR A 350 1 39 HELIX 18 AB9 ASN A 356 SER A 390 1 35 HELIX 19 AC1 SER A 390 CYS A 402 1 13 SHEET 1 AA1 2 PHE A 240 TYR A 247 0 SHEET 2 AA1 2 SER A 250 LEU A 257 -1 O SER A 250 N TYR A 247 SSBOND 1 CYS A 90 CYS A 358 1555 1555 2.04 SSBOND 2 CYS A 174 CYS A 255 1555 1555 2.03 SITE 1 AC1 17 HIS A 150 ASN A 158 VAL A 177 GLN A 181 SITE 2 AC1 17 LYS A 182 VAL A 185 CYS A 255 LYS A 273 SITE 3 AC1 17 TYR A 281 TRP A 336 LEU A 339 HIS A 340 SITE 4 AC1 17 ARG A 343 ILE A 372 SER A 376 HOH A1315 SITE 5 AC1 17 HOH A1336 SITE 1 AC2 9 CYS A 109 PHE A 112 VAL A 113 ILE A 117 SITE 2 AC2 9 ALA A 272 TRP A 275 SER A 279 TRP A 404 SITE 3 AC2 9 OLC A1212 SITE 1 AC3 4 LYS A 175 OLC A1205 OLC A1207 HOH A1377 SITE 1 AC4 1 GLU A 95 SITE 1 AC5 3 VAL A 230 OLC A1203 OLC A1211 SITE 1 AC6 5 VAL A 231 LEU A 232 ILE A 238 THR A 263 SITE 2 AC6 5 TRP A 276 SITE 1 AC7 2 GLU A 172 OLC A1203 SITE 1 AC8 5 LEU A 330 VAL A 331 LEU A 334 CYS A 335 SITE 2 AC8 5 OLC A1210 SITE 1 AC9 4 THR A 99 TRP A 217 LEU A 224 OLC A1211 SITE 1 AD1 6 LEU A 114 LYS A 323 ALA A 381 LEU A 388 SITE 2 AD1 6 VAL A 389 OLC A1208 SITE 1 AD2 4 VAL A 227 VAL A 231 OLC A1205 OLC A1209 SITE 1 AD3 6 VAL A 152 ILE A 153 TYR A 160 TRP A 275 SITE 2 AD3 6 SER A 279 OLC A1202 SITE 1 AD4 6 CYS A 109 LEU A 110 VAL A 113 ALA A 194 SITE 2 AD4 6 GLU A 221 HOH A1338 SITE 1 AD5 6 LYS A 216 THR A1099 PRO A1100 ASN A1101 SITE 2 AD5 6 ARG A1102 HOH A1316 SITE 1 AD6 2 ARG A1033 ARG A1037 SITE 1 AD7 4 PRO A 136 ARG A 199 ARG A 208 LYS A 210 SITE 1 AD8 5 PHE A1071 THR A1072 ASN A1073 SER A1074 SITE 2 AD8 5 ASN A1089 SITE 1 AD9 3 HIS A 314 HOH A1302 HOH A1346 CRYST1 74.130 147.480 108.380 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013490 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006781 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009227 0.00000